Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenues:        
License and collaborative fees $ 1,127 $ 4,859 $ 4,665 $ 16,725
Contract and other 5,905 11,370 20,930 31,624
Net product sales 219 0 795 0
Total revenues 7,251 16,229 26,390 48,349
Operating expenses:        
Research and development 18,381 15,851 52,592 51,479
Selling, general and administrative 4,672 7,296 12,918 18,779
Restructuring 323 0 4,776 0
Cost of sales 28 0 110 0
Total operating expenses 23,404 23,147 70,396 70,258
Loss from operations (16,153) (6,918) (44,006) (21,909)
Other income (expense):        
Interest expense (1,144) (652) (3,211) (1,818)
Other (expense) income (420) 528 (542) (615)
Revaluation of contingent warrant liabilities (9,208) 499 (25,746) 3,349
Net loss before taxes (26,925) (6,543) (73,505) (20,993)
Provision for income tax expense 74 0 74 (15)
Net loss (26,851) (6,543) (73,431) (21,008)
Basic and diluted net loss per common stock (in dollars per share) $ (0.39) $ (0.2) $ (1.22) $ (0.69)
Shares used in computing basic and diluted net loss per share of common stock (in shares) 68,189 32,761 60,239 30,623
Other comprehensive loss:        
Net unrealized gains on available-for-sale securities 7 0 12 0
Comprehensive loss $ (26,844) $ (6,543) $ (73,419) $ (21,008)